Evaluation of routine functional testing after percutaneous coronary intervention - 26/08/11
Doi : 10.1016/j.amjcard.2003.11.071
Mark J. Eisenberg, MD, MPH a, ⁎ 
, James C. Blankenship, MD b, Thao Huynh, MD c, Michael Azrin, MD d, Asad Pathan, MD e, Steven Sedlis, MD f, Manotosh Panja, MD g, Mark R. Starling, MD h, Rafael Beyar, MD i, Arik Azoulay, MSc a, Joanna Caron, BSc a, Louise Pilote, MD, MPH, PhD c
, James C. Blankenship, MD b, Thao Huynh, MD c, Michael Azrin, MD d, Asad Pathan, MD e, Steven Sedlis, MD f, Manotosh Panja, MD g, Mark R. Starling, MD h, Rafael Beyar, MD i, Arik Azoulay, MSc a, Joanna Caron, BSc a, Louise Pilote, MD, MPH, PhD cADORE Investigators*
a Jewish General Hospital, Montreal, Quebec, Canada
b Geisinger Medical Center, Danville, Pennsylvania, USA
c Montreal General Hospital, Montreal, Quebec, Canada
d University of Connecticut, Farmington, Connecticut, USA
e AGA Khan University, Karachi, Pakistan
f Manhattan Veteran Affairs Medical Center, New York, New York, USA
g SSKM Hospital, Calcutta, India
h Veteran Affairs Medical Center, Ann Arbor, Michigan, USA
i Rambam Medical Center, Haifa, Israel
*Dr. Eisenberg's address is: Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University, 3755 Cote Ste. Catherine Road, Suite A-118, Montreal, Quebec H3T 1E2, Canada.
Abstract |
Following percutaneous coronary intervention, 348 patients were randomized to either routine or selective functional testing strategies. For the primary end point of maximal exercise endurance on a treadmill at 9 months, achievement was similar in the routine and selective groups. For the secondary end points measuring functional status and quality of life, scores were also similar. There was little difference in the rates of invasive cardiac procedures for the 2 groups at 9 months.
Le texte complet de cet article est disponible en PDF. | This study was supported by the Quebec Foundation for Health Research, the Réseau en Santé Cardiovasculaire du Quebec, the Heart and Stroke Foundation of Quebec, Montreal, Quebec, Canada, and DuPont Pharma, Saint-Laurent, Quebec, Canada. |
© 2004
Excerpta Medica Inc. Tous droits réservés.
Vol 93 - N° 6
P. 744-747 - mars 2004 Retour au numéro
Article précédent
- Comparison of outcomes up to six months of Heparin-Coated with noncoated stents after percutaneous coronary intervention for acute myocardial infarction
- Eli I. Lev, Abid R. Assali, Igal Teplisky, Eldad Rechavia, David Hasdai, Ofer Sela, Nurit Shor, Alexander Battler, Ran Kornowski
- Predictors of troponin elevation after percutaneous coronary intervention
- Vikram R. Mandadi, Mary C. DeVoe, John A. Ambrose, Anita M. Prakash, Nikita Varshneya, Randy B. Gould, Tien H. Nguyen, Jean-Pierre M. Geagea, Joseph A. Radojevic, Khashayar Sehhat, Rajat S. Barua
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?